Skip to content

Additional Post Hoc Analysis and Clinical Data Collection

Additional Post Hoc Analysis and Clinical Data Collection for Subjects Tested With Brain Network Activation (BNA™) Technology

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02860416
Acronym
BNA™
Enrollment
55
Registered
2016-08-09
Start date
2016-07-31
Completion date
2018-10-31
Last updated
2019-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurological Observations

Keywords

Neurology

Brief summary

The purpose of this study is to collect additional Investigational cognitive tasks and additional clinical data for subjects tested with ElMindA's Brain Network Activation (BNA™).

Detailed description

To collect additional Investigational cognitive tasks and additional clinical data for subjects tested with ElMindA's Brain Network Activation (BNA™). The BNA™ technology was developed and is utilized by ElMindA Ltd. The (BNA™) Analysis System is cleared for use by qualified medical professionals for the post hoc statistical analysis of the human electroencephalogram (EEG), utilizing evoked response potentials (ERP').

Interventions

None listed

Sponsors

ElMindA Ltd
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
8 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Completed a BNA test in the past * Able to speak, read and understand English sufficiently to understand the nature of the study, and to allow completion of all study assessments. * Willingness to participate

Exclusion criteria

* Significant Sensory deficit

Design outcomes

Primary

MeasureTime frameDescription
engineering development according to clinical assessments2 yearsThe study is designed to collect data that will aid in future scientific and engineering exploration of correlations between clinical assessments and BNA scores. The results are primarily intended for scientific inquiry and engineering development purposes.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026